Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma.
| Data(s) |
01/10/2007
|
|---|---|
| Identificador |
http://dx.doi.org/10.1158/1078-0432.CCR-07-0536 http://www.scopus.com/inward/record.url?scp=35348874294&partnerID=8YFLogxK |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Fennell , D 2007 , ' Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma. ' Clinical Cancer Research , vol 13(19) , no. 19 , pp. 5942-5951 . DOI: 10.1158/1078-0432.CCR-07-0536 |
| Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/1300/1306 #Cancer Research #/dk/atira/pure/subjectarea/asjc/2700/2730 #Oncology |
| Tipo |
article |
